Groww Logo
Home>US Stocks>Karyopharm Therapeutics Inc

Karyopharm Therapeutics Inc

Healthcare
$5.13
+0.33 (6.88%)1D
1D
1W
1M
1Y
3Y
5Y

Performance

Today’s Low
$
    Today’s High
    $
    52W Low
    $
      52W High
      $
      Open PricePrev. CloseVolumeAvg. Volume
      $4.84$5.1332,584,942

      Fundamentals

      Market Cap$407.40M
      P/B Ratio-4.9
      P/E Ratio-3.8
      Enterprise Value$432.70M
      Div. Yield0.00%
      Book Value-1.07
      EPS(TTM)-1.41
      ROE116.30%
      Understand Fundamentals

      Company Financials

      *All values are in Million $
      No Graph Data To Display
      Quarterly
      Yearly
      See Details

      Similar Stocks

      COMPANYMARKET PRICECLOSE PRICEMARKET CAP

      FAQs on Karyopharm Therapeutics Inc

      Can I Buy Karyopharm Therapeutics Inc Shares in India?

      Yes, Karyopharm Therapeutics Inc shares can be bought in India by opening an international trading account with Groww.

      How to Buy Karyopharm Therapeutics Inc Shares in India?

      One can easily invest in Karyopharm Therapeutics Inc shares from India by: Direct Investment - Opening an international trading account with Groww which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Karyopharm Therapeutics Inc shares. Indirect Investment - Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Karyopharm Therapeutics Inc.

      What is the Share Price of Karyopharm Therapeutics Inc?

      The share price of Karyopharm Therapeutics Inc is in Dollars and if you are investing from India, you can always check the INR valuation before investing. The current Karyopharm Therapeutics Inc share price is $5.13 as of 24 Jun ‘22

      What is the Market Cap of Karyopharm Therapeutics Inc?

      The Karyopharm Therapeutics Inc market cap is $407.40M as of 24 Jun ‘22

      What is the PE and PB ratio of Karyopharm Therapeutics Inc?

      The PE and PB ratio of Karyopharm Therapeutics Inc is -3.8 and -4.9 as of 24 Jun ‘22
      Want to invest in US Stocks?
      Signup with Groww to get started
      Login / Register
      ⓒ 2016-2022 Groww. All rights reserved, Built with in India
      MOST POPULAR ON GROWWVERSION - 3.1.0
      STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
      MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI